Succination of proteins in diabetes

Free Radical Research

Volumn 45, Issue 1, 2011, Pages 101-109

  Frizzell, Norma ^a   Lima, Maria ^a   Baynes, John W ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Chemical modifi cation of proteins; cysteine; diabetes; endoplasmic reticulum; mitochondria; oxidative stress

Indexed keywords

ACTIN; ADIPONECTIN; CHAPERONE; CYSTEINE; CYTOSKELETON PROTEIN; FUMARIC ACID; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; STREPTOZOCIN; TUBULIN;

ACYLATION; ADIPOCYTE; ADIPOSE TISSUE; CHEMICAL MODIFICATION; CHEMICAL REACTION; CITRIC ACID CYCLE; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; HYPERPOLARIZATION; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEIN SUCCINATION; REVIEW; STREPTOZOCIN DIABETES;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS; HUMANS; OXIDATIVE STRESS; PROTEINS; RATS; SUCCINATES;

RATTUS;

EID: 78650092931     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2010.524643     Document Type: Review

References (50)

1. Pe'er I, Felder CE, Man O, Silman III, Sussman JL, Beck-mann JS. Proteomic signatures: amino acid and oligopeptide compositions differentiate among phyla. Proteins 2004;54: 20-40.
2. Hu W, Tedesco S, Faedda R, Petrone G, Cacciola SA, O'Keefe A, Sheehan D. Covalent selection of the thiol proteome on activated thiol sepharose: a robust tool for redox proteomics. Talanta 2010;80:1569-1575.
3. Kumsta C, Jakob U. Redox-regulated chaperones. Biochem 2009;48:4666-4676.
4. Salmeen A, Barford D. Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antiox Redox Signal 2005;7:560-577. (Pubitemid 40563195)
5. Cross JV, Templeton DJ. Regulation of signal transduction through protein cysteine oxidation. Antiox Redox Signal 2006;8:1819-1827. (Pubitemid 44726354)
6. Webster KA, Prentice H, Bishopric NH. Oxidation of zinc finger transcription factors: physiological consequences. Anti-oxid Redox Signal 2002;3:535-548.
7. Friedman M, Cavins JF, Wall JS. Relative nucleophilic reactivity of amino groups and mercaptide ions in addition reactions with α, β -unsaturated compounds. J Am Chem Soc 1965;87: 3672-3682.
8. Hansen RE, Roth D, Winther JR. Quantifying the global cellular thiol-Disulfide status. Proc Natl Acad Sci USA 2009; 106:422-427.
9. Shackelford RE, Heinloth AN, Heard SC, Paules RS. Cellular and molecular targets of protein S-glutathiolation. Antiox Redox Signal 2005;7:940-950. (Pubitemid 40967145)
10. Dalle-Donne I, Milzani A, Gagliano N, Colombo R, Gius-tarini D, Rossi R. Molecular mechanisms and potential clinical signifi cance of S-glutathionylation. Antiox Redox Signal 2008;10:445-473.
11. Turell L, Botti H, Carballal S, Ferrer-Sueta G, Souza JM, Duran R, Freeman BA, Radi R, Alvarez B. Reactivity of sulfenic acids in human serum albumin. Biochem 2008;47: 358-367.
12. Ronquist G, Theodorsson E. Inherited, non-spherocytic hemolysis due to deficiency of glucose-6-phosphate dehydro-genase. Scand J Clin Lab Invest 2007;67:105-111.
13. Alderson NA, Wang Y, Alt N, Blatnik M, Frizzell N, Nagai R, Walla MD, Carson JA, Thorpe SR, Baynes JW. S-(2-succinyl) cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate. Arch Biochem Biophys 2005; 450:1-8. (Pubitemid 43782733)
14. Brock JW, Hinton DJ, Cotham WE, Metz TO, Thorpe SR, Baynes JW, Ames JM. Proteomic analysis of the site specificity of glycation and carboxymethylation of ribonuclease. J Pro-teome Res 2003;2:506-513. (Pubitemid 37376845)
15. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-1625. (Pubitemid 40770750)
16. Blatnik M, Frizzell N, Thorpe SR, Baynes J W. Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes. Diabetes 2008;57:41-49.
17. Blatnik M, Thorpe SR, Baynes J W. Succination of proteins by fumarate: mechanism of inactivation of glyceraldehydes-3-phosphate dehydrogenase in diabetes. Ann NY Acad Sci 2008;1433:272-275. (Pubitemid 351589309)
18. Sakai K, Hasumi K, Endo A. Identification of koningic acid (heptelidic acid)-modifi ed site in rabbit muscle glyceralde-hydes-3-phosphate dehydrogenase. Biochim Biophys Acta 1991;1077:192-196.
19. Cane DE, Sohng JK. Inhibition of glyceraldehydes-3-phos-phate dehydrogenase by pentalenolactons. 2. Identification of the site of alkylation by tetrahydropentalenolactone. Biochemistry 1994;33:6524-6530. (Pubitemid 24189365)
20. Ishii T, Tatsuda E, Kumazawa S, Nakayama T, Uchida K. Molecular basis of enzyme inactivation by endogenous elec-trophile 4-hydroxy-2-nonenal: Identification of modification sites in glyceraldehydes-3-phosphate dehydrogenase. Biochemistry 2003;42:3474-3480. (Pubitemid 36368641)
21. Yang J, Gibson B, Snider J, Jenkins CM, Han X, Gross RW. Submicromolar concentrations of palmitoyl-CoA specifically thioesterify cysteine 244 in glyceraldehyde-3-phosphate dehydrogenase inhibiting enzyme activity: a novel mechanism potentially underlying fatty acid induced insulin resistance. Biochemistry 2005;44:11903-11912. (Pubitemid 41262725)
22. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates J, Hammes HP, Giardino I, Brownlee M. Normalizing mitochondrial super-oxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790. (Pubitemid 30212409)
23. Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, Brownlee M. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 2003;112:1049-1057. (Pubitemid 38056320)
24. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999;48:1-9. (Pubitemid 29019345)
25. Lin Y, Berg AH, Iyengar P, Lam TKT, Giacca A, Combs TP, Rajala MW, Du X, Rollman B, Li W, Hawkins M, Barzilai N, Rhodes CJ, Fantus IG, Brownlee M, Scherer PE. The hyper-glycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 2005;280: 4617-4626. (Pubitemid 40288630)
26. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006;444: 875-880. (Pubitemid 46028447)
27. Shah A, Mehta N, Reilly MP. Adipose inflammation, insulin resistance, and cardiovascular disease. J Parenter Enteral Nutr 2008;32:638-644.
28. Lai RK, Goldman P. Organic acid profi ling in adipocyte differentiation of 3T3-F442A cells: increased production of Krebs cycle acid metabolites. Metabolism 1992;41: 545-547.
29. Frizzell N, Rajesh N, Jepson MJ, Nagai R, Carson JA, Thorpe SR, Baynes J W. Succination of thiol groups in adipose tissue proteins in diabetes: succination inhibits polymerization and secretion of adiponectin. J Biol Chem 2009;284: 25772-25781.
30. Nagai R, Brock JWC, Blatnik M, Baatz JE, Bethard J, Walla MD, Thorpe SR, Baynes J W, Frizzell N. Succination of protein thiols during adipocyte maturation: a biomarker of mitochondrial stress. J Biol Chem 2007;282: 34219-34228. (Pubitemid 350159439)
31. Frizzell N, Baynes J W. modification of cysteine residues in protein by endogenous oxidants and electrophiles. In: O'Brien PJ, Bruce WR, editors. Endogenous toxins: diet, genetics, disease and treatment. Vol 1. Weinheim, Germany: Wiley VCH; 2009. p 43-58.
32. Giannessi D, Maltinti M, Del Ry S. Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk. Pharm Res 2007;56:459-467. (Pubitemid 350137773)
33. Chang LC, Huang KC, Wu YW, Kao HL, Chen CL, Lai LP, Hwang JJ, Yang WS. The clinical implications of blood adi-ponectin in cardiometabolic disorders. J Formos Med Assoc 2009;108:353-366.
34. Wang Y, Lam KSL, Yau MH, Xu A. Post-translational modi-fi cations of adiponectin: mechanisms and functional implications. Biochem J 2008;409:623-633. (Pubitemid 351214189)
35. Liu M, Liu F. Transcriptional and post-translational regulation of adiponectin. Biochem J 2009;425:41-52.
36. Liu M, Zhou L, Xu A, Lam KSL, Wetzel MD, Xiang R, Zhang J, Xin X, Dong LW, Liu F. A Disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proc Natl Acad Sci USA 2008;105: 18302-18307.
37. Gibala MJ, MacLean DA, Graham TE, Saltin B. Tricarboxy-lic acid cycle intermediate pool size and estimated cycle flux in human muscle during exercise. Am J Physiol 1998; 275:E235-E242.
38. Yin J, Gao Z, He Q, Zhou D, Gu Z, Ye J. Role of hypoxia in obesity-related disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab 2009;296: E333-E342.
39. Wood IS, de Heredia FP, Wang B, Trayhurn P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc 2009;68:370-377.
40. Wang T, Si Y, Shirihai OS, Si H, Schultz V, Corkey RF, Hu L, Deeney JT, Guo W, Corkey BE. Respiration in adi-pocytes is inhibited by reactive oxygen species. Obesity 2010; 18:1493-1502.
41. Townsend DM. Glutathionylation: indicator of cell stress and regulator of the unfolded protein response. Mol Interv 2007;7:313-324.
42. Robertson RP, Harmon JS. Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med 2006;41:177-184. (Pubitemid 43928495)
43. Li J, Wang JJ, Yu Q, Wang M, Zhang SX. Endoplasmic reticu-lum stress is implicated in retinal inflammation and diabetic retinopathy. FEBS Lett 2009;583:1521-1527.
44. Du Y, Miller CM, Kern TS. Hyperglycemia increases mito-chondrial superoxide in retina and retinal cells. Free Radic Biol. Med 2003;35:1491-1499. (Pubitemid 37452474)
45. Luo ZF, Feng B, Mu J, Qi W, Zeng W, Guo YH, Pang Q, Ye ZL, Liu L, Yuan FH. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation. Toxicol Appl Pharmacol 2010;246: 49-57.
46. Fonseca SG, Burcin M, Gromada J, Urano F. Endoplasmic reticulum stress in beta-cells and development of diabetes. Curr Opin Pharmacol 2009;9:763-770.
47. Li J, Wang JJ, Yu Q, Wang M, Zhang SX. Endoplasmic reticu-lum stress is implicated in retinal inflammation and diabetic retinopathy. FEBS Lett 2009;583:1521-1527.
48. Sieber J, Lindenmeyer MT, Kampe K, Campbell KN, Cohen CD, Hopfer H, Mundel P, Jehle AW. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. Am J Physiol Renal Physiol 2010;F821-829.
49. Cnop M, Igoillo-Esteve M, Cunha DA, Ladri è re L, Eizirik DL. An update on lipotoxic endoplasmic reticulum stress in pancreatic beta-cells. Biochem Soc Trans 2008;36: 909-915.
50. Guo W, Wong S, Xie W, Lei T, Luo Z. Palmitate modulates intracellular signaling, induces endoplasmic reticulum stress, and causes apoptosis in mouse 3T3-L1 and rat primary preadipocytes. Am J Physiol Endocrinol Metab 2007;293: E576-E586. (Pubitemid 47205102)